Healthcare -
Biotechnology - NASDAQ - US
$ 1.18
3.51 %
$ 92.7 M
Market Cap
-1.76
P/E
SLS - NET INCOME
Net Income SLS - SELLAS Life Sciences Group, Inc.
-37.3 M
LAST VALUE
-34.31%
2 YEAR CAGR
-6.18%
5 YEAR CAGR
6.94%
10 YEAR CAGR